Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Sep 12, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of NCCIH Technical Assistance Webinar for RFA-AT-23-001 and RFA-AT-23-002
(NOT-AT-22-031)
National Center for Complementary and Integrative Health
- Notice of Increase to NIGMS K99 Support Levels
(NOT-GM-22-045)
National Institute of General Medical Sciences
- Notice of Pre-Application Webinar for the Maternal Health Research Centers of Excellence Funding Opportunity Announcements
(NOT-HD-22-044)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NIH Participation in the NIH-NSF Ecology and Evolution of Infectious Diseases Program
(NOT-TW-22-005)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
- Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Expanding the Development of the Integrated Canine Data Commons
(NOT-CA-22-125)
National Cancer Institute
- Request for Information: Future Research Needs and Infrastructure Support for Newborn Screening Research
(NOT-HD-22-042)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Changes to Funding Opportunities
- Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-051, "HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)"
(NOT-AG-22-033)
National Institute on Aging
- Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-053, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 - Clinical Trial Optional)"
(NOT-AG-22-034)
National Institute on Aging
- Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-054, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 - Clinical Trial Optional)"
(NOT-AG-22-035)
National Institute on Aging
- Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-049, "HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)"
(NOT-AG-22-036)
National Institute on Aging
- Notice of NCCIH Participation in PAR-22-181, "NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
(NOT-AT-22-030)
National Center for Complementary and Integrative Health
- Notice of Change to Award Information for RFA-DK-22-506 and RFA-DK-22-507, Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
(NOT-DK-22-029)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Additional Receipt Date for RFA-ES-19-011 "Mechanism for Time-Sensitive Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)"
(NOT-ES-22-013)
National Institute of Environmental Health Sciences
- Notice of NEI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
(NOT-EY-22-015)
National Eye Institute
- Notice of Early Termination of NOT-OD-22-031, Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-22-209)
Office of Research on Women's Health
Notices of Special Interest
- Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
(NOT-OD-22-202)
Office of Dietary Supplements
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions
(NOT-OD-22-203)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Nursing Research
- Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-22-208)
Office of Research on Women's Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Funding Opportunities
- Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed)
(PAR-22-204)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional)
(PAR-22-230)
National Institute of Nursing Research
- NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)
(PAR-22-231)
National Institute of Nursing Research
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
(PAR-22-242)
National Cancer Institute
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
(PAR-22-243)
National Cancer Institute
National Institute of Neurological Disorders and Stroke
- NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)
(RFA-DA-23-037)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
- Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed)
(RFA-HD-23-003)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Office of Dietary Supplements
- Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)
(RFA-HG-22-008)
National Human Genome Research Institute
National Cancer Institute
National Institute of Environmental Health Sciences
- Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed)
(RFA-HG-22-009)
National Human Genome Research Institute
National Cancer Institute
National Institute of Environmental Health Sciences
- Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed)
(RFA-HG-22-010)
National Human Genome Research Institute
National Cancer Institute
National Institute of Environmental Health Sciences
- Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
(RFA-OD-22-013)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).
